Gastroretentive Drug Delivery Outsourcing Market: Growth Potential and Outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Gastroretentive Drug Delivery Systems Outsourcing Market Between 2026 And 2030?
The gastroretentive drug delivery systems outsourcing market has demonstrated substantial growth in recent years. Its size is anticipated to expand from $1.49 billion in 2025 to $1.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. Historically, this market’s expansion can be ascribed to several factors including the limitations of conventional oral drug delivery, the growth in CRO services, the ongoing need for improved drug absorption, the expansion of pharmaceutical development pipelines, and advancements in formulation technology.
The gastroretentive drug delivery systems outsourcing market size is anticipated to undergo significant expansion in the coming years. It is projected to climb to $2.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This forecasted growth can be attributed to the increasing prevalence of complex drug molecules, the growing demand for patient-centric delivery systems, the expansion of outsourcing strategies, ongoing innovation in gastroretentive technologies, and pharmaceutical companies’ initiatives for cost optimization. Prominent trends for the forecast period include the increasing outsourcing of advanced drug delivery development, a rising need for formulations that offer prolonged GI retention, the growing adoption of floating drug delivery systems, an expansion of CRO partnerships in formulation development, and a concentrated focus on enhancing drug bioavailability.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Gastroretentive Drug Delivery Systems Outsourcing Market Landscape?
The increasing occurrence of gastrointestinal conditions is anticipated to drive expansion in the gastroretentive drug delivery systems outsourcing market in the future. These conditions encompass various illnesses impacting the digestive tract, such as the stomach, liver, gallbladder, intestines, and pancreas. The rise in gastrointestinal disorders is attributed to factors like aging populations, antibiotic usage, infectious agents, shifts in diet, stress and lifestyle, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms gain the necessary resources and specialized knowledge to manage the rising challenges posed by gastrointestinal disorders, thereby enhancing patient well-being and life quality. As an illustration, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government-funded research institute and public health agency, indicated that 60 to 70 million people were affected by various digestive diseases. Consequently, the growing prevalence of gastrointestinal disorders is fueling the gastroretentive drug delivery systems outsourcing market.
Which Segments Define The Gastroretentive Drug Delivery Systems Outsourcing Market Segment Structure?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) By Floating Systems: Single Unit Systems, Multiple Unit Systems
2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
What Market Trends Are Affecting The Gastroretentive Drug Delivery Systems Outsourcing Market?
Leading firms operating within the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative products, such as ready-to-fill (RTF) colon functional capsules, to enhance drug delivery efficiency and user convenience. These ready-to-fill (RTF) colon functional capsules are pre-manufactured, empty capsules intended for filling with specific formulations or active ingredients targeting the colon. For instance, in September 2024, Evonik, a Germany-based advanced drug delivery provider, launched EUDRACAP colon functional capsules, specifically engineered for the targeted delivery of oral drugs to the ileo-colonic region. These innovative capsules represent the market’s initial ready-to-fill offering, designed to deliver sensitive active ingredients such as live biotherapeutic products (LBPs). While currently available in technical grade, a GMP-grade product is also under development. EUDRACAP colon significantly improves the oral drug development process by simplifying formulation and expediting time to market, thereby marking a substantial advancement in gastroretentive drug delivery systems.
Who Are The Established Players Within The Gastroretentive Drug Delivery Systems Outsourcing Market?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Get The Full Gastroretentive Drug Delivery Systems Outsourcing Market Report:
Which Region Accounts For The Largest Portion Of The Gastroretentive Drug Delivery Systems Outsourcing Market?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastroretentive Drug Delivery Systems Outsourcing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2026, By The Business Research Company
Advanced Drug Delivery Systems Market Report 2026
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Electronic Drug Delivery Systems Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
